The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent.
wherein, a broken line means the presence or absence of a bond; R
1
is substituted or unsubstituted alkyl etc., R
2
is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R
3
is a substituted or unsubstituted aromatic carbocyclic group; R
4
is a hydrogen atom etc.; R
5
is a substituted or unsubstituted aromatic carbocyclic group etc.; Y is a single bond etc.; R
6
is substituted or unsubstituted alkyl; R
7
is —Z—R
71
etc.; Z is —NR
72
—CO— etc.; R
71
is substituted or unsubstituted alkyl etc.; R
72
is a hydrogen atom etc.
The present invention relates to compounds having the structure
useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
本发明涉及具有以下结构的化合物,用作钾通道抑制剂,用于治疗心律失常等。
US7879839B2
申请人:——
公开号:US7879839B2
公开(公告)日:2011-02-01
US9199959B2
申请人:——
公开号:US9199959B2
公开(公告)日:2015-12-01
Nickel-Catalyzed Reductive Amidation of Unactivated Alkyl Bromides
作者:Eloisa Serrano、Ruben Martin
DOI:10.1002/anie.201605162
日期:2016.9.5
A user‐friendly, nickel‐catalyzed reductive amidation of unactivated primary, secondary, and tertiary alkylbromides with isocyanates is described. This catalytic strategy offers an efficient synthesis of a wide range of aliphatic amides under mild conditions and with an excellent chemoselectivity profile while avoiding the use of stoichiometric and sensitive organometallic reagents.